Literature DB >> 25408095

Prevalence of Rhodopsin mutations in autosomal dominant Retinitis Pigmentosa in Spain: clinical and analytical review in 200 families.

Patricia Fernandez-San Jose1, Fiona Blanco-Kelly, Marta Corton, Maria-Jose Trujillo-Tiebas, Ascension Gimenez, Almudena Avila-Fernandez, Blanca Garcia-Sandoval, Maria-Isabel Lopez-Molina, Inma Hernan, Miguel Carballo, Rosa Riveiro-Alvarez, Carmen Ayuso.   

Abstract

PURPOSE: We aimed to determine the prevalence of mutations in the RHO gene in Spanish families with autosomal dominant Retinitis Pigmentosa (adRP), to assess genotype-phenotype correlations and to establish an accurate diagnostic algorithm after 23 years of data collection. PATIENTS AND METHODS: Two hundred patients were analysed through a combination of denaturing gradient gel electrophoresis, single-strand conformation polymorphism, genotyping microarray and Sanger sequencing of the RHO gene.
RESULTS: Overall, 42 of 200 Spanish adRP families were mutated for RHO (21.0%). Twenty-seven different RHO mutations were detected; seven of them were novel. A genotype-phenotype correlation was established with clinical data from 107 patients. The most prevalent p.Pro347Leu mutation, responsible for 4.5% (9/200) of all mutated adRP families, was associated with a phenotype of early onset and severe course diffuse RP.
CONCLUSIONS: This retrospective study provides a wide spectrum of mutations in the RHO gene in Spanish patients with adRP. Also, the prevalence of mutations is similar to that reported in European population. Genotyping microarray followed by RHO sequencing is proposed as a first step in molecular diagnosis of adRP Spanish families. An increasing understanding of causal RHO alleles in adRP facilitates disease diagnosis and prognosis, especially for the prevalent p.Pro347Leu mutation.
© 2014 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  RHO; Retinitis Pigmentosa; Spanish families; autosomal dominant; diagnostic algorithm; genotype-phenotype correlation

Mesh:

Substances:

Year:  2014        PMID: 25408095     DOI: 10.1111/aos.12486

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  14 in total

1.  Rhodopsin gene mutation analysis in Iranian patients with autosomal dominant retinitis pigmentosa.

Authors:  Danial Roshandel; Maryam Rafati; Sara Khorami; Nima Novin Baheran; Setareh Jalali; Razieh Tabatabaie; Safura Rezai; Hamid Ahmadieh; Saeed Reza Ghaffari
Journal:  Int Ophthalmol       Date:  2019-04-10       Impact factor: 2.031

2.  A novel MERTK mutation causing retinitis pigmentosa.

Authors:  Hasenin Al-Khersan; Kaanan P Shah; Segun C Jung; Alex Rodriguez; Ravi K Madduri; Michael A Grassi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-05-01       Impact factor: 3.117

3.  Retinal histopathology in eyes from patients with autosomal dominant retinitis pigmentosa caused by rhodopsin mutations.

Authors:  Vera L Bonilha; Mary E Rayborn; Brent A Bell; Meghan J Marino; Craig D Beight; Gayle J Pauer; Elias I Traboulsi; Joe G Hollyfield; Stephanie A Hagstrom
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-07-23       Impact factor: 3.117

4.  Genetic Analysis of the Rhodopsin Gene Identifies a Mosaic Dominant Retinitis Pigmentosa Mutation in a Healthy Individual.

Authors:  Avigail Beryozkin; Gal Levy; Anat Blumenfeld; Segev Meyer; Prasanthi Namburi; Yair Morad; Libe Gradstein; Anand Swaroop; Eyal Banin; Dror Sharon
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-03       Impact factor: 4.799

5.  Dominant Retinitis Pigmentosa, p.Gly56Arg Mutation in NR2E3: Phenotype in a Large Cohort of 24 Cases.

Authors:  Fiona Blanco-Kelly; María García Hoyos; Miguel Angel Lopez Martinez; Maria Isabel Lopez-Molina; Rosa Riveiro-Alvarez; Patricia Fernandez-San Jose; Almudena Avila-Fernandez; Marta Corton; Jose M Millan; Blanca García Sandoval; Carmen Ayuso
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

6.  Efficacy of Column Scatter Plots for Presenting Retinitis Pigmentosa Phenotypes in a Japanese Cohort.

Authors:  Ken Ogino; Akio Oishi; Maho Oishi; Norimoto Gotoh; Satoshi Morooka; Masako Sugahara; Tomoko Hasegawa; Manabu Miyata; Nagahisa Yoshimura
Journal:  Transl Vis Sci Technol       Date:  2016-03-04       Impact factor: 3.283

7.  In silico Mapping of Protein Unfolding Mutations for Inherited Disease.

Authors:  Caitlyn L McCafferty; Yuri V Sergeev
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

8.  Mutations in Splicing Factor Genes Are a Major Cause of Autosomal Dominant Retinitis Pigmentosa in Belgian Families.

Authors:  Caroline Van Cauwenbergh; Frauke Coppieters; Dimitri Roels; Sarah De Jaegere; Helena Flipts; Julie De Zaeytijd; Sophie Walraedt; Charlotte Claes; Erik Fransen; Guy Van Camp; Fanny Depasse; Ingele Casteels; Thomy de Ravel; Bart P Leroy; Elfride De Baere
Journal:  PLoS One       Date:  2017-01-11       Impact factor: 3.240

9.  Targeted next generation sequencing identified novel loss-of-function mutations in MERTK gene in Chinese patients with retinitis pigmentosa.

Authors:  Song Liu; Jian Gang Bi; Yunlong Hu; Donge Tang; Bo Li; Peng Zhu; Wujian Peng; Dong Du; Huiyan He; Jun Zeng; Yong Dai
Journal:  Mol Genet Genomic Med       Date:  2019-02-20       Impact factor: 2.183

Review 10.  Stem Cell Therapy for Treatment of Ocular Disorders.

Authors:  Padma Priya Sivan; Sakinah Syed; Pooi-Ling Mok; Akon Higuchi; Kadarkarai Murugan; Abdullah A Alarfaj; Murugan A Munusamy; Rukman Awang Hamat; Akihiro Umezawa; Suresh Kumar
Journal:  Stem Cells Int       Date:  2016-05-15       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.